Clinical trial
Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Treatment of Uncomplicated Skin and Soft Tissue Infections
NCT03637400 is registered in ClinicalTrials.gov with Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Treatment of Uncomplicated Skin and Soft Tissue Infections
- Lead sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 26, 2018
- Completion date
- June 30, 2025
- Enrollment
- 269 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
methicillin-resistant staphylococcus aureus, skin infection